Ribavirin Tablet, Film Coated
Product Images NDC 65862-207

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 65862-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg (168 Tablet Bottle)

Label for Ribavirin Tablets USP 200 mg, film-coated tablets provided by Aurobindo Pharma Limited. The label includes NDC 65862-207-68, pharmacist dispensing instructions, storage conditions, distributor information (Aurobindo Pharma USA, Inc.), and a pregnancy warning. The package contains 168 tablets and states the medication guide must be dispensed separately.*

FDA Label Image

Chemical Structure (Ribavirin Str)

Chemical structure of Ribavirin showing its molecular arrangement including a triazole carboxamide group and a ribose sugar moiety. The diagram depicts the positions of nitrogen atoms, hydroxyl groups, and the amide functional group characteristic of Ribavirin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.